Initial experience with primary and redo robotic pyeloplasty using the Versius robotic system (CMR).

Area of Science:

• Urology
• Minimally Invasive Surgery
• Robotic Surgery

Background:

• Robotic-assisted pyeloplasty is a standard minimally invasive treatment for pelvi-ureteric junction obstruction (PUJO).
• The Versius Robotic System (CMR) is an advanced robotic platform increasingly adopted in urologic procedures.
• This study assesses robotic pyeloplasty outcomes using the Versius system at a major research center.

Purpose of the Study:

• To evaluate the safety and efficacy of robotic pyeloplasty for primary and redo PUJO.
• To analyze perioperative outcomes and patient recovery following robotic pyeloplasty with the Versius system.
• To determine the feasibility of the Versius Robotic System in managing PUJO.

Main Methods:

• A retrospective analysis of 74 patients undergoing robotic pyeloplasty between May 2023 and July 2025.
• Data collected included patient demographics, intraoperative details, and postoperative results.
• Outcomes were assessed for both primary and redo pyeloplasty procedures.

Main Results:

• 74 patients (65 primary, 9 redo) underwent robotic pyeloplasty with the Versius system.
• Mean operative time was 157.1 minutes, with a 5.4% conversion rate to open surgery.
• All patients (100%) reported symptomatic improvement, and 82.4% showed radiological improvement.

Conclusions:

• Robotic pyeloplasty with the Versius system is safe and effective for primary and redo PUJO.
• The procedure demonstrates favorable perioperative results and facilitates rapid patient recovery.
• The Versius system is a viable option for managing PUJO with excellent outcomes.